Repligen (RGEN) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Repligen (RGEN) Reports In-Line Q4 EPS

Repligen Reports Fourth Quarter and Year 2015 Financial Results

February 25, 2016 7:30 AM EST

- Constant currency revenue growth of 45% for the fourth quarter, 47% for the year -- Gross margin expansion of 420 basis points to 57.8% for the year -- Non-GAAP adjusted EPS of $0.40, an increase of 67% for the year -

WALTHAM, Mass., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the fourth quarter and year ended December 31, 2015. Below are the Company's performance highlights for these periods, followed by financial guidance for the year 2016 and access information for today's... More